Evidence map›Paper›PMID 34742689›Full record

ReviewExperimental neurology2022

How the placenta-brain lipid axis impacts the nutritional origin of child neurodevelopmental disorders: Focus on attention deficit hyperactivity disorder and autism spectrum disorder.

Tomo Tarui, Aisha Rasool, Perrie O'Tierney-Ginn

Open access · greenAbstract readReview
In one paragraph

Review in Experimental neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Perfluorooctanoic acid induces transcriptomic alterations in second trimester human cytotrophoblasts.Toxicological sciences : an official journal of the Society of Toxicology · 2023
    Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tomo TaruiMother Infant Research Institute, Tufts Medical Center, Boston, MA, United States of America.
Aisha RasoolMother Infant Research Institute, Tufts Medical Center, Boston, MA, United States of America.
Perrie O'Tierney-GinnMother Infant Research Institute, Tufts Medical Center, Boston, MA, United States of America. Electronic address: potierneyginn@tuftsmedicalcenter.org.
Tufts Medical Center · US

Funding

Placental lipid metabolism impacts fetal adiposity and is programmed by the maternal metabolic milieu in early pregnancyR01HD091054 · NICHD · TUFTS MEDICAL CENTER · PI O'TIERNEY-GINN, PERRIE F · 2017 to 2022
$2.5M
Prenatal diagnosis of brain malformations: Improving assessment of prognosisK23HD079605 · NICHD · TUFTS MEDICAL CENTER · PI TARUI, TOMO · 2015 to 2019
$767k
NICHD NIH HHS K23 HD079605NICHD NIH HHS R01 HD091054
6 · The paper itself

Abstract

Dietary fish is a rich source of omega-3 (n-3) fatty acids, and as such, is believed to have played an important role in the evolution of the human brain and its advanced cognitive function. The long chain polyunsaturated fatty acids, particularly the n-3 docosahexanoic acid (DHA), are critical for proper neurological development and function. Both low plasma DHA and obesity in pregnancy are associated with neurodevelopmental disorders such as attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) in childhood, and n-3 supplementation has been shown to improve symptoms, as reviewed herein. The mechanisms underlying the connection between maternal obesity, n-3 fatty acid levels and offspring's neurological outcomes are poorly understood, but we review the evidence for a mediating role of the placenta in this relationship. Despite promising data that n-3 fatty acid supplementation mitigates the effect of maternal obesity on placental lipid metabolism, few clinical trials or animal studies have considered the neurological outcomes of offspring of mothers with obesity supplemented with n-3 FA in pregnancy.

Indexed as

AnimalsAttention Deficit Disorder with HyperactivityAutism Spectrum DisorderBrainDietary SupplementsFatty Acids, Omega-3FemaleHumansLipid MetabolismNeurodevelopmental DisordersPlacentaPregnancyPregnancy in ObesityFatty Acids, Omega-3DHAMetabolismN-3 fatty acidsNeurodevelopmental disordersPlacenta

Identifiers

PMID34742689
PMCPMC12720271
OpenAlexW3210201834

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.